Raise awareness of environmental health issues in order to better protect our children and future generations.

EMF Studies

23 June 2016

Lyme Disease: Prof. Luc Montagnier Denounces the Inefficiency of Text Protocols

Lyme disease: Prof. Montagnier denounces the inefficiency of test protocols
archyxx.com, 19 June 2016 (translated text from French by archyxx with grammatical corrections by the Editor of "Towards Better Health")

Lyme disease, transmitted by tick bites, is poorly diagnosed and treated in France, due to a “great ignorance about its chronic nature,” the Nobel Prize for medicine Luc Montagnier said Sunday, at a conference in Strasbourg.

He said he made promising discoveries to better diagnose the condition.

“It is unfortunate that governments and health authorities do not have a coherent policy on Lyme disease,” denounced the co-discoverer of the AIDS virus.

“There is currently total ignorance on the subject by much of the medical community and science”, said Professor Montagnier, who was speaking during a study day devoted to this pathology, organized by “Lyme without borders”, an association of angry sick persons against the official approach of the disease.

For Professor Montagnier, 83, the tests used today to detect the Lyme bacteria give too many “false negatives” because they are based on the detection of antibodies, while some infected patients do not develop these.

The scientist, who works in Paris in a research institute that bears his name, is seeking to develop a diagnostic method of detecting blood plasma traces of the DNA of the bacteria, capturing electromagnetic waves emitted by the sample.

“I think this test is more reliable than those currently in force,”  said the Nobelist, while agreeing that this electromagnetic approach was “not recognized by a number of scientists, so it is hard to validate.”

27,000 new cases of Lyme disease are officially reported each year in France, but according to the association “Lyme without borders”, this figure is in fact much greater, in the order of “ten times”.

Detected too late, this condition – for which there is no vaccine – can have severe and debilitating neurological consequences for patients.

According to the members, many patients, sometimes confined to a wheelchair,  have “wandered” from doctor to doctor and sometimes treated as hypochondriacs for lack of a proper diagnosis.

More than 200 of them, embittered that they were announced as not having the disease – so they say and are now being treated with antibiotics for this, after months or years of medical wandering – are preparing to file suit against pharmaceutical companies that market tests.

“We will hold the laboratories liable for compensation for patients who were not diagnosed properly or on time,” said one of the lawyers responsible for this action, Mr. Julien Fouray, on Sunday.

“In the second phase, we will seek responsibilities against the state, which validated and imposed a test protocol that is known as unreliable,” he said.

The civil proceedings will be initiated “by the end of June or early July” before the high courts of Paris and Lyon, said the lawyer.

Based on a blood sample, the incriminated tests of the type “Elisa” are produced by half a dozen laboratories, including BioMérieux and Diasorin.

The protest of Lyme patients against the official disease approach is also subject to other legal proceedings: the former manager of a biological analysis laboratory and a pharmacist, will appear on October 7 before the Colmar court of appeals for implementing alternative methods of diagnosis and treatment of disease. Condemned in the first instance to suspended prison sentences, they are considered as “whistleblowers” by members of “Lyme without borders”.

No comments:

Post a Comment